MR imaging in ovarian cancer

Cancer Imaging

Volumn 7, Issue SPEC. ISS. A, 2007, Pages

  Sohaib, S A A ^a   Reznek, R H ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Adnexal masses; MR imaging; Ovarian cancer

Indexed keywords

CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; EPITHELIUM TUMOR; GERM CELL TUMOR; HUMAN; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; OVARY METASTASIS; OVARY TUMOR; RECURRENT CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; SEX CORD TUMOR; DIFFERENTIAL DIAGNOSIS; FEMALE; METHODOLOGY; PATHOLOGY; PROGNOSIS;

CONTRAST MEDIUM;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 35848965033     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2007.9046     Document Type: Review

References (61)

1. Bammer R, Schoenberg SO. Current concept and advances tri,clinicAl parallel magnetic in clinical parallel magnetic resonance imaging. Top Main Reson Imaging 2004; 15: 129-58.
2. Forstner R, Hricak H, Occhipinti KA, Powell CB, Frankel SD, Stern JL, Ovarian cancer: staging with CT and MR imaging. Radiology 1995; 197: 619-26.
3. Low RN. Sigeti JS. MR. imaging of peritoneal disease. AJR 1994; 163: 1131-40.
4. Ghossain MA, Buy JN, Ligneres C, et al. Epithelial tumors of the ovary: comparison of MR and CT findings. Radiology 1991; 181: 863-70.
5. Thurnher S, Hodler J, Baer S, Marincek B, von Schulthess GK. Gadolinium-DOTA enhanced MR imaging of adnexal tumors. J Comput Assist Tomogr 1990; 14: 939-49.
6. Katayama M, Masui T, Kobayashi S, et al. Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients? J Comput Assist Tomogr 2002; 26: 250-6.
7. Kinkel K, Hricak. H, Lu. Y, Tsuda K,-Filly RA. US characterization of ovarian masses: a meta-analysis. Radiology 2000; 217: 803-11.
8. Sohaib SA, Mills TD, Sahaev A, et al. The role of magnetic resonance imaging and ultrasound in patients with adnexal masses. Clin Radiol 2005; 60: 340-8.
9. Yamashita Y, Torashima M, Hatanaka Y, et al. Adnexal masses: accuracy of characterization with transvaginal US and precontrast and postcontrast MR imaging: Radiology 1995; 194: 557-65.
10. Komatsu T, Konishi I, Mandai M, et al. Adnexal masses: transvaginal US and gadolimium-enhanced MR imaging assessment of intratumoral structure. Radiology 1996; 198: 109-15.
11. Rieber A, Nussle K. Stohr I, et al. Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. AJR Am J Roentgenol 2001; 177: 123-9.
12. Kinkel K, Lu Y, Mehdizade A, Pelte MF, Hricak H. Indeterminate ovarian mass at US: incremental value of secoud imaging test for characterization-meta-analysis and Bayesian analysis. Radiology 2005; 236: 85-94.
13. Engelen MJ, Bongaerts AH, Sluiter WJ, et al. Distinguishing benign and malignant pelvic masses: the value of different diagnostic methods in every day clinical practice. Eur J Obstet Gynecol Reprod Biol 2006 (E-pub ahead of print).
14. Davies AP, Jacobs I, Woolas R, Fish A, Oram D. The adnexal mass: benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol 1993; 100: 921-31.
15. Van Trappen PO, Rufford BD, Mills TD, et al. Differential diagnosis of adnexal masses: risk of malignancy index, ultrasonography, magnetic resonance imaging, and radioimmunoscintigraphy. Int J Gynecol Cancer 2007; 17: 61-7.
16. Sohaib SA, Sahdev A, Van Trappen PO, Jacobs IJ, Reznek RH. Characterization of adnexal mass lesions on MR imaging. AJR Am J Roentgenol 2003; 180: 1297-304.
17. Hricak H, Chen M, Coakley FV, et al. Complex adnexal masses: detection and characterization with MR imaging-multivariate analysis. Radiology 2000; 214: 39-46.
18. Forstner R, Hricak H, White S. CT and MRI of ovarian cancer (Review). Abdom Imaging 1995; 20: 2-8.
19. Buy JN, Ghossain AM Sciot C, et al. Epithelial tumors of the ovary: CT findings and correlation with US. Radiology 1991; 178: 811-18.
20. Troiano RN, Lazzarini KM, Scoutt LM, Lange RC, Flynn SD, McCarthy S. Fibroma and fibrothecoma of the ovary: MR imaging findings. Radiology 1997; 204: 795-8.
21. Outwater EK, Siegelman ES, Talerman A, Dunton C. Ovarian fibromas and cystadenofibromas: MRI features of the fibrous component. J Magn Reson Imaging 1997; 7: 465-71.
22. Togashi K, Nishimura K, Kimura I, et al. Endometrial cysts: diagnosis with MR imaging. Radiology 1991; 180: 73-8.
23. Tanaka YO, Yoshizako T, Nishida M, Yamaguchi M, Sugimura K, Itai Y. Ovarian carcinoma in patients with endometriosis: MR imaging findings. AJR Am J Roentgenol 2000; 175: 1423-30.
24. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol 1990; 75: 1023-8.
25. McMeekin DS, Burger RA, Manetta A, DiSaia P, Berman ML. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis. Gynecol Oncol 1995; 59: 81-6.
26. Stevens SK, Hzicak H, Stern JL. Ovarian lesions: detection and characterization with gadolinium- enhanced MR imaging at 1.5 T. Radiology 1991; 181: 481-8.
27. deSouza NM, O'Neill R, McIndoe GA, Dina R, Soutter WP. Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage 1 disease. AIR Am J Roentgenol 2005; 184: 999-1003.
28. Stevens SK, Hricak H, Campos Z. Teratomas versus cystic hemorrhagic adnexal lesions: differentiation with proton-selective fat-saturation MR imaging. Radiology 1993; 186: 481-8.
29. Rha SE, Byun JY, Jung SE, et al. Atypical CT and MRI manifestations of mature ovarian cystic teratomas. AJR Am J Roentgenol 2004; 183: 743-50.
30. Comerci Jr JT, Licciardi F, Bergh PA, Gregori C, Breen JL. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol 1994; 84: 22-8.
31. Kido A, Togashi K, Konishi I, et al. Dermoid cysts of the ovary with malignant transformation: MR appearance. AJR Am J Roentgenol 1999; 172: 445-9.
32. Tanaka YO, Kurosaki Y, Nishida M, et al. Ovarian dysgerminoma: MR and CT appearance. J Comput Assist Tomogr 1994; 18: 443-8.
33. Kim SH, Kang SB. Ovarian dysgerminoma: color Doppler ultrasonographic findings and comparison with CT and MR imaging findings. J Ultrasound Med 1995; 14: 843-8.
34. Jung SE, Rha SE, Lee JM, et al. CT and MRI findings of sex cordstromal tumor of the ovary. AJR Am J Roentgenol 2005; 185: 207-15.
35. MacSweeney JE, King DM. Computed tomography, diagnosis, staging and follow-up of pure granulosa cell tumour of the ovary. Clin Radiol 1994; 49: 241-5.
36. Schwartz RK, Levine D, Hatabu H, Edelman RR. Ovarian fibroma: findings by contrast-enhanced MRI. Abdom Imaging 1997; 22: 535-7.
37. Stevens SK The adnexa. In: Higgins CB, Hricak H, Helms CA, editors: Magnetic resonance imaging of the body. 2nd ed. New York: Raven Press; 1992, p. 865-89.
38. Brown DL, Zou KH, Tempany CM, et al. Primary versus secondary ovarian malignancy: imaging findings of adnexal masses in the Radiology Diagnostic Oncology Group Study Radiology 2001; 219: 213-18.
39. Outwater EK, Dunton CJ. Imaging of the ovary and adnexa: clinical issues and applications of MR imaging. Radiology 1995; 194: 1-18.
40. Mitchell DG, Hill MC, Hill S, Zaloudek C. Serous carcinoma of the ovary: CT identification of metastatic calcified implants. Radiology 1986; 158: 649-52.
41. Low RN, Carter WD, Saleli F, Sigeti JS. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT. Radiology 1995; 195: 391-400.
42. Payer LM, Stiglbauerg R, Kramer J, et al. Superparamagnetic particles as oral contrast medium in MRI of patients with treated ovarian cancer - comparison with plain MRI. Br J Radiol 1993; 66: 415-19.
43. Potter ME, Partridge EE, Hatch KD, Soong SJ, Austin JM, Shingleton HM. Primary surgical therapy of ovarian cancer: how much and when. Gynecol Oncol 1991; 40: 195-200.
44. Walsh JW. CT of gynaecologic neoplasm. Radiol Clin North Am 1992; 30: 826-830.
45. Coakley FV. Staging ovarian cancer: role of imaging. Radiol Clin. North Am 2002; 40: 609-36.
46. Fleischer AC. Transabdominal and transvaginal sonography of ovarian masses. Clin Obstet Gynaecol 1991; 34: 433.
47. Sanders RC, McNeil BJ, Finberg HJ, et al. A prospective study of computed tomography and ultrasound in the detection and staging of pelvic masses. Radiology 1983; 14: 439-42.
48. Shiels RA, Peel KR, MacDonald HN, et al. A prospective trial of CT in staging of ovarian malignancy. Br J Obstet Gynaecol 1985; 92: 407-12.
49. Jokuson RJ, Blackledge G, Eddleston B, Crowther D. Abdomino-pelvic computed tomography in the management of ovarian carcinoma. Radiology 1983; 146: 447-52.
50. Blaquiere RM, Husband JE. Conventional radiology and computed tomography in ovarian cancer: discussion paper. J R Soc Med 1983; 76: 574-9.
51. Axtell AE, Lee MH, Bristow RE, et al. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol 2007; 25: 384-9.
52. Meyer JI, Kennedy AW, Friedman R, Ayoub A, Zepp RC. Ovarian carcinoma: value of CT in predicting success of debulking surgery. AJR Am J Roentgenol 1995; 165: 875-8.
53. Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 1993; 11: 166-72.
54. Semelka RC, Lawrence PH, Shoenut JP, et al. Primary ovarian cancer: prospective comparison of contrast-enhanced CT and pre-and postcontrast, fat-suppressed MR imaging, with histologic correlation. J Magn Reson Imaging 1993; 3: 99-106.
55. Prayer L, Kainz C, Kramer J, et al. CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer. J Comput Assist Tomogr 1993; 17: 626-32.
56. Goldhirsch A, Triller M Greiner R, Dreher E, Davis BW. Computed tomography prior to second-look operation in advanced ovarian cancer. Obstet Gynecol 1983; 62: 630-4.
57. Moskovic E, Fernando I, Blake P, Parsons C. Lymphography - current role in oncology. Br J Radiol 1991; 64: 422-7.
58. Silverman PM, Osborne M, Dunnick NR, Bandy LC. CT prior to second look operation in ovarian cancer. AJR Am J Roentgenol 1988; 150: 829-32.
59. Forstner R, Hricak H, Powell CB, Azizi L, Frankel SB, Stern JL. Ovarian cancer recurrence: value of MR imaging. Radiology 1995; 196: 715-20.
60. Low RN, Saleh F, Song SY, et al. Treated ovarian cancer: comparison of MR imaging with serum CA-125 level and physical examination - a longitudinal study. Radiology 1999; 211: 519-28.
61. Low RN, Duggan B, Barone RM, Saleh F, Song SY. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology 2005; 235: 918-26.